Defining the right diluent for intravenous infusion of therapeutic antibodies

• 主要な著者: Shen Luo (著者), Keisha Melodi McSweeney (著者), Tao Wang (著者), Silvia M. Bacot (著者), Gerald M. Feldman (著者), Baolin Zhang (著者)
• フォーマット: 図書
• 出版事項: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Therapeutic monoclonal antibodies (mAbs) are commonly administered to patients through intravenous (IV) infusion, which involves diluting the medication into an infusion solution (e.g., saline and 5% dextrose). Using the wrong diluent can cause product aggregation, which may compromise patient safet...